antiphospholipid syndrome
antiphospholipid syndrome
Explore linked clinical trials. Standard reference: MONDO:800001047 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases | Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, musculoskeletal system disorder, necrotizing vasculitis, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis | Recruiting | Early phase 1 | 2026-09-23 | NCT07301164 | |
| Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases | Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic sclerosis, vascular disorder, vasculitis | Recruiting | Phase 1 / Phase 2 | 2026-09-22 | NCT06828042 | |
| Daratumumab in Primary Antiphospholipid Syndrome | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT05671757 | |
| Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE | Embolism and Thrombosis, antiphospholipid syndrome, autoimmune disease, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, immune system disorder, ischemic stroke, nervous system disorder, stroke disorder, thrombotic disease, transient ischemic attack, vascular disorder | Active, not recruiting | Phase 4 | 2026-09-11 | NCT05995600 | |
| Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies | Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, autoimmune disease, cardiovascular disorder, connective tissue disorder, immune system disorder, necrotizing vasculitis, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis | Recruiting | Not stated | 2026-08-20 | NCT07251179 | |
| Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort Study | Cytopenia, Hemic and Lymphatic Diseases, antiphospholipid syndrome, autoimmune disease, blood platelet disease, hematologic disorder, immune system disorder, thrombocytopenia | Recruiting | Not applicable | 2026-08-11 | NCT07757789 | |
| Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Not applicable | 2026-08-10 | NCT07743242 | |
| Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research | Aortic Arch Syndromes, Behcet disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, Spondylarthritis, Stomatognathic Diseases, Takayasu arteritis, Tako-tsubo cardiomyopathy, Ventricular Dysfunction, Ventricular Dysfunction, Left, acquired idiopathic inflammatory myopathy, anterior uveitis, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, aortic disorder, arteritis, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, bone disorder, brain disorder, cardiomyopathy, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, connective tissue disorder, eye disorder, heart disorder, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, juvenile idiopathic arthritis, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myocarditis, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, panuveitis, pericarditis, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, spondylitis, spondyloarthropathy, systemic sclerosis, systemic-onset juvenile idiopathic arthritis, temporal arteritis, uveal disorder, uveitis, vascular disorder, vasculitis, vertebral column disorder | Not yet recruiting | Not stated | 2026-08-10 | NCT07737470 | |
| Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Not stated | 2026-07-31 | NCT07142239 | |
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | Behcet disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, anterior uveitis, antiphospholipid syndrome, autoimmune disease, blood coagulation disease, blood platelet disease, bullous pemphigoid, cardiovascular disorder, connective tissue disorder, dermatomyositis, eye disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, panuveitis, polymyositis, purpura, skin disorder, skin vascular disease, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy, uveal disorder, uveitis, vascular disorder, vasculitis, vesiculobullous skin disease | Recruiting | Phase 1 | 2026-07-22 | NCT06371417 | |
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases | Aortic Arch Syndromes, Axial Spondyloarthritis, Cerebral Small Vessel Diseases, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, Takayasu arteritis, ankylosis, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, aortic disorder, arteritis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, connective tissue disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, juvenile idiopathic arthritis, lung disorder, microscopic polyangiitis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, psoriasis, psoriatic arthritis, respiratory system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, skin vascular disease, spondylitis, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis, vertebral column disorder | Recruiting | Phase 4 | 2026-07-20 | NCT07087912 | |
| Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) | Behcet disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, anterior uveitis, antiphospholipid syndrome, autoimmune disease, blood coagulation disease, blood platelet disease, bullous pemphigoid, cardiovascular disorder, connective tissue disorder, dermatomyositis, eye disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, panuveitis, polymyositis, purpura, skin disorder, skin vascular disease, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy, uveal disorder, uveitis, vascular disorder, vasculitis, vesiculobullous skin disease | Enrolling by invitation | Phase 1 | 2026-07-17 | NCT06723106 | |
| A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis | Embolism and Thrombosis, antiphospholipid syndrome, autoimmune disease, cardiovascular disorder, immune system disorder, thrombotic disease, vascular disorder | Active, not recruiting | Phase 1 | 2026-06-08 | NCT07632976 | |
| Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial) | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Phase 2 | 2026-06-02 | NCT07584083 | |
| Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Not stated | 2026-05-29 | NCT00482794 | |
| Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome | Constriction, Pathologic, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, antiphospholipid syndrome, autoimmune disease, immune system disorder | Enrolling by invitation | Not stated | 2026-05-26 | NCT05583305 | |
| International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants | Embolism and Thrombosis, antiphospholipid syndrome, autoimmune disease, cardiovascular disorder, immune system disorder, thrombotic disease, vascular disorder | Recruiting | Not stated | 2026-05-08 | NCT04262492 | |
| Point of Care Testing INR in Antiphospholipid Syndrome | antiphospholipid syndrome, autoimmune disease, immune system disorder | Not yet recruiting | Not applicable | 2026-05-06 | NCT07570511 | |
| Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, acute transverse myelitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, connective tissue disorder, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, myasthenia gravis, myositis disease, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic lupus erythematosus, systemic sclerosis | Recruiting | Phase 1 | 2026-05-06 | NCT07085676 | |
| Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) | Skin and Connective Tissue Diseases, antiphospholipid syndrome, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Not stated | 2026-04-28 | NCT00198068 | |
| An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Urogenital Diseases, Xerostomia, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, dry eye syndrome, eye disorder, glomerulonephritis, immune system disorder, kidney disorder, lacrimal apparatus disorder, lupus nephritis, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nephritis, nervous system disorder, neuromuscular disease, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, urinary system disorder, vascular disorder, vasculitis | Recruiting | Phase 1 | 2026-03-04 | NCT07236762 | |
| Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases | Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis | Recruiting | Phase 1 | 2026-03-02 | NCT07236801 | |
| A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Skin and Connective Tissue Diseases, Urogenital Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, autoimmune disease, cardiovascular disorder, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nephritis, nervous system disorder, neuromuscular disease, skin disorder, skin vascular disease, systemic lupus erythematosus, urinary system disorder, vascular disorder, vasculitis | Recruiting | Phase 1 | 2026-03-02 | NCT07123519 | |
| A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases | Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Skin and Connective Tissue Diseases, Urogenital Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, autoimmune disease, cardiovascular disorder, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nephritis, nervous system disorder, neuromuscular disease, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, urinary system disorder, vascular disorder, vasculitis | Recruiting | Phase 1 | 2026-03-02 | NCT07104721 | |
| YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases | Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, cardiovascular disorder, connective tissue disorder, diffuse scleroderma, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, vascular disorder, vasculitis | Not yet recruiting | Phase 1 | 2026-02-27 | NCT07439029 |